These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 534166)
21. Neuroendocrine aspects in monitoring of dopaminergic drugs in man. Hietala J; Koulu M; Scheinin M; Syvälahti E Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892 [TBL] [Abstract][Full Text] [Related]
22. [Nycterohemeral variations of growth hormone and prolactin in 6 Parkinson's sufferers treated with bromocriptine (author's transl)]. Passouant P; Besset A; Descomps B; Bonardet A; Billiard M; Nègre C Nouv Presse Med; 1979 Oct; 8(40):3237-42. PubMed ID: 534183 [TBL] [Abstract][Full Text] [Related]
23. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome. Ayalon D; Eckstein N; Avidan S; Eshel A; L'Hermite M; Caufriez A; Spitz I; Zylber-Haran E Gynecol Obstet Invest; 1983; 16(2):97-106. PubMed ID: 6413305 [TBL] [Abstract][Full Text] [Related]
24. Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding. Foord SM; Peters JR; Dieguez C; Jasani B; Hall R; Scanlon MF Endocrinology; 1984 Jul; 115(1):407-15. PubMed ID: 6428863 [TBL] [Abstract][Full Text] [Related]
26. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism. Felt V; Nedvdková J Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253 [TBL] [Abstract][Full Text] [Related]
27. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease. Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870 [TBL] [Abstract][Full Text] [Related]
28. [Effect of bromocrytine on the secretion of thyrotropic hormone and growth hormone (author's transl)]. Pombo M; Feliu L; Martínez-Sapiña MJ; Martínez MD; Alvez F; Iglesias-Diz JL; Devesa J; Bravo M; Pereira J; Tojo T An Esp Pediatr; 1980 Jun; 13(6):497-502. PubMed ID: 6774646 [TBL] [Abstract][Full Text] [Related]
29. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine]. Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547 [TBL] [Abstract][Full Text] [Related]
30. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas. Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713 [TBL] [Abstract][Full Text] [Related]
31. [The sella turcica and pituitary function in congenital hypothyroidism due to thyroid ectopia or hypogenesis (author's transl)]. Fossati P; Lefèbvre J; Asfour M; Granier F; Foulinnie JC; L'Hermite M; Golstein J Nouv Presse Med; 1977 Dec; 6(45):4177-82. PubMed ID: 416419 [TBL] [Abstract][Full Text] [Related]
33. Dissociation of thyrotropin and prolactin responsiveness to thyrotropin releasing hormone stimulation in L-dopa treated parkinsonian patients. Rabey JM; Vardi Y; Ravid R; Ayalon D Horm Res; 1981; 15(2):78-87. PubMed ID: 6799381 [TBL] [Abstract][Full Text] [Related]
34. Central dopaminergic system plays a role in the analgesic action of paracetamol: Preclinical evidence. Bhagyashree A; Manikkoth S; Sequeira M; Nayak R; Rao SN Indian J Pharmacol; 2017; 49(1):21-25. PubMed ID: 28458418 [TBL] [Abstract][Full Text] [Related]
35. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154). Delitala G; Masala A; Alagna S; Devilla L IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172 [No Abstract] [Full Text] [Related]
36. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)]. Ulm G Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619 [No Abstract] [Full Text] [Related]
37. Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma. Seki K; Kato K; Shima K J Clin Endocrinol Metab; 1986 Apr; 62(4):783-4. PubMed ID: 3512593 [TBL] [Abstract][Full Text] [Related]
38. [Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone]. Boiadzhieva N; Zakharieva B; Ovcharov R Eksp Med Morfol; 1985; 24(1):29-32. PubMed ID: 3928331 [No Abstract] [Full Text] [Related]
39. [Bromocriptine in Parkinsonian syndromes. Results obtained in a group of patients treated for 8 months]. Quattrini A; Paggi A; Del Pesce M; Di Bella P Riv Patol Nerv Ment; 1978; 99(3):150-63. PubMed ID: 752907 [TBL] [Abstract][Full Text] [Related]
40. Prolactin inhibition at the end of lactation programs for a central hypothyroidism in adult rat. Bonomo IT; Lisboa PC; Passos MC; Alves SB; Reis AM; de Moura EG J Endocrinol; 2008 Aug; 198(2):331-7. PubMed ID: 18490438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]